Filing Details

Accession Number:
0001140361-18-016002
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-29 20:50:47
Reporting Period:
2018-03-28
Accepted Time:
2018-03-29 20:50:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1656328 Sienna Biopharmaceuticals Inc. SNNA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1207792 J Robert More C/O Sienna Biopharmaceuticals, Inc.
30699 Russell Ranch Road, Suite 140
Westlake Village CA 91362
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-03-28 10,000 $18.84 193,249 No 4 S Direct
Common Stock Disposition 2018-03-29 14,429 $18.78 178,820 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. This transaction was executed in multiple trades in prices ranging from $18.8213 to $18.869, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  2. This transaction was executed in multiple trades in prices ranging from $18.75 to $18.99, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.